Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Oct-24 4:06 PM View:  | Aastrom Biosciences, Inc. (VCEL) | 02-Oct-24 | Option Exercise | 5,833 | $13.05 | $76,120.60 | 53% 11.0K to 16.83K | |
| 04-Oct-24 4:06 PM View: | Aastrom Biosciences, Inc. (VCEL) | 02-Oct-24 | Planned Option Sale | 5,833 | $40.35 | $235,362.00 | (35%) 16.83K to 11.0K | |
| 20-Sep-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 18-Sep-24 | Option Exercise | 5,834 | $13.05 | $76,133.70 | 53% 11.0K to 16.83K | |
| 20-Sep-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 18-Sep-24 | Planned Option Sale | 5,834 | $45.54 | $265,680.00 | (35%) 16.83K to 11.0K | |
| 05-Sep-24 4:06 PM View: | Aastrom Biosciences, Inc. (VCEL) | 04-Sep-24 | Option Exercise | 5,000 | $3.74 | $18,700.00 | 45% 11.0K to 16.0K | |
| 05-Sep-24 4:06 PM View: | Aastrom Biosciences, Inc. (VCEL) | 04-Sep-24 | Planned Option Sale | 5,000 | $48.58 | $242,900.00 | (31%) 16.0K to 11.0K | |
| 10-Jun-24 4:19 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-24 | Grant | 30,000 | -- | -- | 34% 87.13K to 117.13K | |
| 03-May-24 4:06 PM View: | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 41% 7.8K to 11.0K | |
| 23-Jun-23 4:12 PM View: | SCYNEXIS, Inc. (SCYX) | 15-Jun-23 | Grant | 10,000 | -- | -- | 71% 14.0K to 24.0K | |
| 08-Jun-23 4:07 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-23 | Grant | 30,000 | -- | -- | 53% 57.13K to 87.13K | |
| 28-Apr-23 4:04 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Apr-23 | Option Exercise | 2,600 | -- | -- | 50% 5.2K to 7.8K | |
| 22-Jun-22 4:03 PM View: | SCYNEXIS, Inc. (SCYX) | 17-Jun-22 | Grant | 10,000 | -- | -- | 250% 4.0K to 14.0K | |
| 09-Jun-22 4:58 PM View: | Akebia Therapeutics, Inc. (AKBA) | 08-Jun-22 | Grant | 13,700 | -- | -- | 32% 43.43K to 57.13K | |
| 07-Jun-22 4:03 PM View: | Akebia Therapeutics, Inc. (AKBA) | 03-Jun-22 | Sale (Planned) | 4,567 | $0.36 | $1,653.25 | (10%) 48.0K to 43.43K | |
| 02-May-22 4:07 PM View: | Aastrom Biosciences, Inc. (VCEL) | 29-Apr-22 | Sale | 900 | $30.94 | $27,846.00 | (15%) 6.1K to 5.2K | |
| 29-Apr-22 4:12 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Apr-22 | Option Exercise | 2,600 | -- | -- | 74% 3.5K to 6.1K | |
| 01-Dec-21 4:07 PM View: | Aastrom Biosciences, Inc. (VCEL) | 29-Nov-21 | Option Exercise | 5,000 | $3.74 | $18,700.00 | 143% 3.5K to 8.5K | |
| 01-Dec-21 4:07 PM View: | Aastrom Biosciences, Inc. (VCEL) | 29-Nov-21 | Market Option Sale | 5,000 | $39.17 | $195,855.00 | (59%) 8.5K to 3.5K | |
| 28-Oct-21 4:12 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Oct-21 | Option Exercise | 5,000 | $3.74 | $18,700.00 | 143% 3.5K to 8.5K | |
| 28-Oct-21 4:12 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Oct-21 | Market Option Sale | 5,000 | $50.57 | $252,870.00 | (59%) 8.5K to 3.5K | |
| 01-Oct-21 4:12 PM View: | Aastrom Biosciences, Inc. (VCEL) | 30-Sep-21 | Option Exercise | 5,000 | $3.74 | $18,700.00 | 143% 3.5K to 8.5K | |
| 01-Oct-21 4:12 PM View: | Aastrom Biosciences, Inc. (VCEL) | 30-Sep-21 | Market Option Sale | 5,000 | $48.85 | $244,255.00 | (59%) 8.5K to 3.5K | |
| 09-Jun-21 4:26 PM View: | Akebia Therapeutics, Inc. (AKBA) | 07-Jun-21 | Market Sale (Planned) | 4,567 | $3.32 | $15,163.40 | (9%) 52.56K to 48.0K | (8%) |
| 03-Jun-21 5:26 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Jun-21 | Grant | 13,700 | -- | -- | 35% 38.86K to 52.56K | |
| 30-Apr-21 4:02 PM View: | Aastrom Biosciences, Inc. (VCEL) | 28-Apr-21 | Option Exercise | 1,750 | -- | -- | 100% 1.75K to 3.5K | |
| 23-Dec-20 9:06 AM View: | SCYNEXIS, Inc. (SCYX) | 21-Dec-20 | Market Purchase | 4,000 | $6.25 | $25,000.00 | 100% 0 to 4.0K | 6% |
| 01-Oct-20 5:14 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 01-Oct-20 | Disposition | 7,796 | -- | -- | (100%) 7.8K to 0 | |
| 07-Aug-20 5:04 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 05-Aug-20 | Option Exercise | 13,000 | $10.63 | $138,190.00 | 167% 7.8K to 20.8K | |
| 07-Aug-20 5:04 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 05-Aug-20 | Planned Private Option Sale | 13,000 | $32.75 | $425,750.00 | (63%) 20.8K to 7.8K | |
| 30-Jul-20 7:03 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 29-Jul-20 | Option Exercise | 10,000 | $10.63 | $106,300.00 | 128% 7.8K to 17.8K | |
| 30-Jul-20 7:03 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 29-Jul-20 | Planned Private Option Sale | 10,000 | $29.70 | $297,000.00 | (56%) 17.8K to 7.8K | |
| 23-Jul-20 5:55 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 22-Jul-20 | Grant | 10,000 | $10.63 | $106,300.00 | 128% 7.8K to 17.8K | |
| 23-Jul-20 5:55 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 22-Jul-20 | Private Sale (Planned) | 10,000 | $33.23 | $332,300.00 | (56%) 17.8K to 7.8K | |
| 09-Jun-20 4:17 PM View: | Akebia Therapeutics, Inc. (AKBA) | 08-Jun-20 | Market Sale (Planned) | 4,567 | $12.08 | $55,169.40 | (11%) 43.43K to 38.86K | 75% |
| 09-Jun-20 4:17 PM View: | Akebia Therapeutics, Inc. (AKBA) | 05-Jun-20 | Grant | 13,700 | -- | -- | 46% 29.73K to 43.43K | |
| 01-May-20 4:15 PM View: | Aastrom Biosciences, Inc. (VCEL) | 29-Apr-20 | Option Exercise | 1,750 | -- | -- | 100% 0 to 1.75K | |
| 22-Nov-19 6:20 AM View: | Akebia Therapeutics, Inc. (AKBA) | 20-Nov-19 | Market Purchase | 5,800 | $3.43 | $19,894.00 | 24% 23.93K to 29.73K | (12%) |
| 21-Jun-19 4:15 PM View: | Momenta Pharmaceuticals Inc. (MNTA) | 20-Jun-19 | Option Exercise | 4,356 | -- | -- | 127% 3.44K to 7.8K | |
| 10-Jun-19 4:04 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-19 | Grant | 13,700 | -- | -- | 134% 10.23K to 23.93K | |
| 03-May-19 4:07 PM View: | Aastrom Biosciences, Inc. (VCEL) | 01-May-19 | Option Exercise | 7,500 | $2.76 | $20,700.00 | 100% 0 to 7.5K | |
| 03-May-19 4:07 PM View: | Aastrom Biosciences, Inc. (VCEL) | 01-May-19 | Market Option Sale | 7,500 | $16.81 | $126,094.00 | (100%) 7.5K to 0 | |
| 04-Mar-19 4:01 PM View: | Aastrom Biosciences, Inc. (VCEL) | 28-Feb-19 | Option Exercise | 7,500 | $2.76 | $20,700.00 | 100% 0 to 7.5K | |
| 04-Mar-19 4:01 PM View: | Aastrom Biosciences, Inc. (VCEL) | 28-Feb-19 | Market Option Sale | 7,500 | $18.02 | $135,129.00 | (100%) 7.5K to 0 | |
| 13-Dec-18 4:35 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 27,333 | -- | -- | (100%) 27.33K to 0 | |
| 13-Dec-18 6:40 PM View: | Akebia Therapeutics, Inc. (AKBA) | 12-Dec-18 | Grant | 10,231 | -- | -- | 100% 0 to 10.23K | |
| 04-Dec-18 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 03-Dec-18 | Option Exercise | 8,500 | $2.63 | $22,355.00 | 100% 0 to 8.5K | |
| 04-Dec-18 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 03-Dec-18 | Market Option Sale | 8,500 | $17.75 | $150,908.00 | (100%) 8.5K to 0 | |
| 06-Sep-18 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 04-Sep-18 | Option Exercise | 9,000 | $2.63 | $23,670.00 | 100% 0 to 9.0K | |
| 06-Sep-18 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 04-Sep-18 | Market Option Sale | 9,000 | $12.03 | $108,270.00 | (100%) 9.0K to 0 | |
| 12-Jul-18 6:01 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jun-18 | Grant | 10,000 | -- | -- | 58% 17.33K to 27.33K |